Biosyntech (Biosyntech) Change In Payables And Accrued Expense

: $-0.53 Mil (TTM As of Dec. 2009)

View and export this data going back to 2000. Start your Free Trial

Biosyntech's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2009 was $-0.09 Mil. It means Biosyntech's Accounts Payable & Accrued Expense declined by $0.09 Mil from Sep. 2009 to Dec. 2009 .

Biosyntech's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2009 was $0.25 Mil. It means Biosyntech's Accounts Payable & Accrued Expense increased by $0.25 Mil from Mar. 2008 to Mar. 2009 .

Biosyntech Change In Payables And Accrued Expense Historical Data

The historical data trend for Biosyntech's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech Annual Data

Trend

Mar00

Mar01

Mar02

Mar03

Mar04

Mar05

Mar06

Mar07

Mar08

Mar09

Change In Payables And Accrued Expense

0.11

0.34

0.19

0.06

0.25

Biosyntech Quarterly Data
	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09
Change In Payables And Accrued Expense																0.65	-0.47	-0.41	0.44	-0.09

Biosyntech Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.53 Mil.

Biosyntech Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Biosyntech's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyntech (Biosyntech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3

Website

http://www.biosyntech.com

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines